 |
|
 |
|
"Exploring Stem Cells"
Malcolm Alison, Centre for Diabetes & Metabolic Medicine, Institute of Cell & Molecular Science, Queen Mary's School of Medicine & Dentistry
|
|
|
|
|
|
"The role of drug transport proteins in drug absorption and tissue distribution"
Per Artursson, Department of Pharmacy, Uppsala University, Sweden
|
|
|
|
|
|
"Omics Technology in Safety Assessment"
Remi Bars
|
|
|
|
|
|
"Human Mesenchymal Stem Cells from Adipose Tissue: Differentiation into Hepativ Lineage"
Ana Bonora Centelles, Unidad de Hepatologia Experimental, Centro de Investigacion, Hospital La Fe, Valencia, Spain
|
|
|
|
|
|
"In vitro models of the Blood-Brain Barrier and their use in drug development"
Romeo Cecchelli
|
|
|
|
|
|
"Overview of the Blood-Brain Barrier and its proerties"
Romeo Cecchelli
|
|
|
|
|
|
"Cell-Based Microassays: Current Status, Future Prospects"
Tom Freeman, Scottish Centre of Genome Technology and Informatics (GTI), University of Edinburgh Medical School
|
|
|
|
|
|
"Development of an in vitro model for pulmonary translocation of nanoparticles"
Jorina Geys, K.U.Leuven, Unit for Lung Toxicology
|
|
|
|
|
|
"Pancraetic Stem Cells: An In-Vitro Study"
N.J. Guppy, Institute of Cellular and Molecular Science, QMUL, London, UK
|
|
|
|
|
|
"New Technologies for optimized Gene Silencing"
Bettina Hädrich, Global Product Manager, Qiagen
|
|
|
|
|
|
"In vitro monitoring of vaccine (antigen) quality"
Coenraad Hendriksen, Netherlands Vaccine Institute (NVI) & Netherlands Centre Alternatives to Animal use, Utrecht University
|
|
|
|
|
|
"Trans-Epithelial Electrical Resistance (TEER) monitoring in perfusion culture"
Thomas Lechleitner, Department of Physiology and Medical Physics, Innsbruck Medical University, Austria
|
|
|
|
|
|
"Phenotypic strategies for kinase inhibitor discovery"
Marcel Leist, Doerenkamp-Zbinden Chair for Alternative In Vitro Methods, Faculty of Science and Mathematics, University of Konstanz, Germany
|
|
|
|
|
|
"Expression of cell cycle regulatory genes in the proliferation, cell cyclearrest and terminal differentiation of CACO-2 cells"
Bruno Leoni, Igea D'Agnano, Armando Felsani, Flavio Zucco, CNR, Instituo di Neurobiologia e Medicina Molecolare, Roma, Italy
|
|
|
|
|
|
"Production of antigens and antibodies in plants: alternative technology"
George Lomonssoff, John Innes Centre, Norwich, UK
|
|
|
|
|
|
"Models of the Choroid Plexus Epithelium"
Anne Mahringer, Ruprecht-Karls-University Hamburg, Institute of Pharmacy and Molecular Biotechnology (IPMB)
|
|
|
|
|
|
"IFNα induced nephrotoxicity involves an apoptotic cell death pathway"
Judith Lechner, Nadia Malloth, Thomas Seppi, Walter Pfaller
|
|
|
|
|
|
|
"Development of a novel multicellular 3-dimensional blood brain barrier in vitro model"
Omolara Ogunshota, Vetsuisse Faculty, Institute of Veterinary Physiology and Zurich Center for Integrative human physiology, University of Zurich, Switzerland
|
|
|
|
|
|
"Potential novel technologies as test basis for new regulatory screens: lessions to learn from ICH approaches"
Klaus Olejnicak, Federal Institute for Drugs and Medical Devices
|
|
|
|
|
|
"Chromaffin cells in culture as in vitro alternative model to study the organophosphorus induced delayed neuropathy"
Encarna Quesada
|
|
|
|
|
|
"ecopa - European Consensus Platform on 3R-Alternatives"
Vera Rogiers
|
|
|
|
|
|
"Effects of urban PM2.5 on airway, epithelial cells in vitro, Expression of EGFR ligands "
Melina Rumelhard
|
|
|
|
|
|
"In vitro pulmonary alveolar type II cell models - not an easy task!"
Sara Signorelli, Department of Physiology and Medical Physics, Innsbruck Medical University, Austria
|
|
|
|
|
|
"In Vitro screening of azole fungicides for antiandrigenic effects - comparison with in vitro effects"
Camilla Taxvig, Danish Institute for Food and Veterinary Research, Dept. of Toxicology and Risk Assessment
|
|
|
|
|
|
"Ocular Cell Culture Models"
Arto Urtti, Drug Discovery and Development Technology Center (DDTC), University of Helsinki, Finland
|
|
|
|
|
|
"Development of a custom-made microarray as an alternative tool for a endrocine disruptors"
Caroline Vanparys, Marleen Maras,Karlijn van der Veen, Johan Robbens, Ronny Blust and Wim De Coen
|
|
|
|
|
|
"An electrophysiological approach for acute in vitro neurotoxicity screening"
Erwin van Vliet, European Centre for the Validation of Alternative Methods (ECVAM), Joint Research Centre Ispra, Italy
|
|
|
|
|
|
"Characterization of a renal cell model by gene expression analysis"
Christina Weiland, Molecular and Special Toxicology, Bayer Healthcare AG
|
|
|
|
|
|
"Innovative R&D Solutions for Respiratory Diseases and Chemical Testing"
Ludovic Wiszniewski
|
|
|
|
|
|
"The computational physical chemistry methods as predictors of pharmacokinetics"
Marjo Yliperttula
|
|
|
